Veradermics Incorporated
Organization details
- Legal name
- Veradermics Incorporated
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- New Haven
- Headquarters state / province
- Connecticut
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MANE
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001827635
- EIN
- 84-3304423
Board of directors
-
Aaron Cowen · DirectorSince 2026
-
David Matthew Friedman · DirectorSince 2026
-
Jane M. Grant-Kels · DirectorSince 2026
-
John W. Childs · DirectorSince 2026
-
Katarina Pance · DirectorSince 2026
- Since 2026
-
Reid Alexander Waldman · Director · Chief Executive OfficerSince 2026
-
Vlad Coric · DirectorSince 2026
Chief executives
Board connections
6 of this board's directors also sit on 9 other boards. 9 are in the same sector.
-
Benitec Biopharma Inc. Same sectorvia Aaron Cowen and David Matthew Friedman
-
Biohaven Ltd. Same sectorvia John W. Childs and Vlad Coric
-
Achieve Life Sciences Inc. Same sectorvia Reid Alexander Waldman
-
Avalyn Pharma Inc. Same sectorvia David Matthew Friedman
-
BioAge Labs Inc. Same sectorvia Patrick G. Enright
-
Jazz Pharmaceuticals plc Same sectorvia Patrick G. Enright
-
Royalty Pharma plc Same sectorvia Vlad Coric
-
Vera Therapeutics Inc. Same sectorvia Patrick G. Enright
-
Zenas BioPharma Inc. Same sectorvia Patrick G. Enright
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $54,092,449
- 26 purchases by 5 insiders
- Sold, last 12 months
- $103,119,917
- 15 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | David Hollander Officer (Chief R&D Officer) | Grant or award | +9,650 | — | — |
| Aug 20, 2026 | Averill Master Fund, Ltd. Director | In-the-money exercise | +149,000 | — | — |
| Aug 20, 2026 | Averill Master Fund, Ltd. Director | In-the-money exercise | +151,000 | — | — |
| Aug 19, 2026 | Averill Master Fund, Ltd. Director | Open-market sale | −690,601 | $107.25 | $74,066,957 |
| Aug 19, 2026 | Averill Master Fund, Ltd. Director | Open-market sale | −59,399 | $107.25 | $6,370,543 |
| Aug 17, 2026 | Durso Timothy August Officer (Chief Technical Officer) | Option exercise | +3,452 | $12.19 | $42,080 |
| Aug 17, 2026 | Reid Alexander Waldman Director, Officer (Chief Executive Officer) | Option exercise | +3,452 | $12.19 | $42,080 |
| Aug 17, 2026 | Durso Timothy August Officer (Chief Technical Officer) | Open-market sale | −7,918 | $106.71 | $844,930 |
| Aug 17, 2026 | Reid Alexander Waldman Director, Officer (Chief Executive Officer) | Open-market sale | −11,527 | $106.72 | $1,230,161 |
| Aug 17, 2026 | Durso Timothy August Officer (Chief Technical Officer) | Open-market sale | −16,306 | $107.52 | $1,753,221 |
| Aug 17, 2026 | Reid Alexander Waldman Director, Officer (Chief Executive Officer) | Open-market sale | −25,234 | $107.53 | $2,713,412 |
| Aug 17, 2026 | Durso Timothy August Officer (Chief Technical Officer) | Open-market sale | −16,767 | $108.38 | $1,817,207 |
| Aug 17, 2026 | Reid Alexander Waldman Director, Officer (Chief Executive Officer) | Open-market sale | −27,490 | $108.45 | $2,981,291 |
| Aug 17, 2026 | Durso Timothy August Officer (Chief Technical Officer) | Open-market sale | −2,348 | $109.34 | $256,730 |
| Aug 17, 2026 | Reid Alexander Waldman Director, Officer (Chief Executive Officer) | Open-market sale | −3,000 | $109.38 | $328,140 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Veradermics Incorporated
Who is the CEO of Veradermics Incorporated?
Reid Alexander Waldman has been Veradermics Incorporated's Chief Executive Officer since February 2026.
How many directors are on Veradermics Incorporated's board?
Veradermics Incorporated's board has 8 directors: Aaron Cowen, David Matthew Friedman, Jane M. Grant-Kels, John W. Childs, Katarina Pance, Patrick G. Enright, Reid Alexander Waldman and Vlad Coric.
Are Veradermics Incorporated insiders buying or selling shares?
Over the last 12 months, Veradermics Incorporated insiders bought $54.1 million of shares in 26 purchases and sold $103.1 million of shares in 15 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="veradermics-incorporated"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.